Showing results (81-90 of 131) with videos related to
Sort By:
Pageof 14
Neurology|March 13, 2002
ALS and PDC of Guam: forty-year follow-upC C Plato, D Galasko, R M Garruto, et al.Neurology|July 29, 2011
A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer diseaseM Sano, K L Bell, D Galasko, et al.Neurology|September 1, 1996
ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guamX Chen, Y Xia, L S Gresham, et al.Neurology|December 1, 1993
The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's diseaseJ C Morris, S Edland, C Clark, et al.Annals of Neurology|January 1, 1995
The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's diseaseT Saitoh, Y Xia, X Chen, et al.Neurology|December 1, 1995
Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adultsM W Bondi, D P Salmon, A U Monsch, et al.Archives of Neurology|September 1, 1994
Clinical-neuropathological correlations in Alzheimer's disease and related dementiasD Galasko, L A Hansen, R Katzman, et al.Annals of Neurology|July 1, 1983
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptineJ E Granato, B J Stern, A Ringel, et al.Alzheimer Disease and Associated Disorders|January 1, 1997
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative StudyJ A Mackell, S H Ferris, R Mohs, et al.Neurology|January 1, 1990
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entityL Hansen, D Salmon, D Galasko, et al.Pageof 14